ArticleFrontiers in neurology2025
Triple sheath neuroendoscopic combination technique for managing complete intraventricular hemorrhage casting in patients with cerebral hemorrhage.
Article in Frontiers in neurology, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- Comparative effectiveness of neuroendoscopic surgery and stereotactic aspiration for brain hemorrhage.Frontiers in surgery · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
7 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Objective: To evaluate the efficacy of the triple sheath neuroendoscopic combination technique (TSNCT) compared to standard endoscopic hematoma removal and external ventricular drainage (EVD) for managing complete intraventricular hemorrhage (IVH) casting in patients with cerebral hemorrhage. Methods: A retrospective analysis was conducted on five patients with complete IVH casting treated at our institution between 2023 and 2024, including two treated with TSNCT, two with standard endoscopic hematoma removal, and one with EVD. Preoperative and postoperative imaging, intraoperative neuroendoscopic video, and clinical data were reviewed. The TSNCT involves an outer sheath for ventricular access, a middle sheath for maneuverability, and a mini sheath designed to navigate the midbrain aqueduct. Results: TSNCT enabled near-complete evacuation of hematomas, including in the midbrain aqueduct, achieving a mean hematoma clearance rate of 93.5% in the two TSNCT cases, compared to 91.7% for standard endoscopic removal and 27.2% for EVD. TSNCT cases showed greater neurological improvement [mean Glasgow Coma Scale (GCS) increase of 7 points] than standard endoscopic removal (3 points) and EVD (no improvement). TSNCT addresses high mortality associated with severe hemorrhage involving all ventricular chambers, with fewer complications in this small cohort. Conclusion: TSNCT offers a novel approach to overcome anatomical challenges in complete IVH casting, enhancing surgical precision and showing potential for improved patient outcomes. Further research with larger cohorts is needed to validate these preliminary findings and standardize its application in neurosurgical practice.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.